Hill September 3, 2024
- Semaglutide, known as Ozempic and Wegovy, may reduce COVID-19 reactions
- That includes severe side effects and even death
- Study found ‘consistently lower rates’ of all-cause death while taking it
(NewsNation) — The popular weight loss drugs Ozempic and Wegovy may reduce the rates of severe COVID-19 reactions, including death, a new study found.
Published in the Journal of the American College of Cardiology, the trial examined 17,604 people over more than three years.
It found that, while taking semaglutide once a weekly did not reduce rates of COVID-19 overall, it led to fewer “COVID-19 related adverse events.”
Placebo-takers recorded a 3.1% occurrence, while those on the weight loss drugs noted 2.6%.
Participants were:
- 45...
Today's Sponsors
Today's Sponsor